| Identification | Back Directory | [Name]
Pradefovir | [CAS]
625095-61-6 | [Synonyms]
Hepavir B
Remofovir mesylate
Pradefovir mesilate
Pradefovir mesylate (Remofovir)
Pradefovir mesylate (Remofovir mesylate)
Pradefovir mesylate (Synonyms: Remofovir mesylate) | [Molecular Formula]
C18H23ClN5O7PS | [MDL Number]
MFCD08435984 | [MOL File]
625095-61-6.mol | [Molecular Weight]
519.89 |
| Chemical Properties | Back Directory | [Melting point ]
186.5-188 °C | [storage temp. ]
Store at -20°C | [form ]
Solid | [color ]
White to off-white | [Water Solubility ]
Water : ≥ 125 mg/mL (240.43 mM) |
| Hazard Information | Back Directory | [Uses]
Antiviral. | [in vivo]
Daily oral dosing of Pradefovir (300 mg/kg) to rats for 8 days does not affect body weight; liver weight; liver weight-body weight ratio; liver microsomal protein content; total CYP content; enzyme activities for CYP1A, CYP2B, and CYP3A; and apoprotein contents for CYP1A1, CYP2B1/2, CYP3A1/2, and CYP4A1/3, indicating that Pradefovir is not a CYP inducer in rats[1]. | [IC 50]
CYP3 | [storage]
Store at -20°C |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|